Healthy Participants Clinical Trial
Official title:
The Comparative Gastric Volume Estimation Between Different Time Intervals by Ultrasonography After Glucose Loaded Clear Fluid Ingestion in Fasted Healthy Adult
Introduction; Pre operative gastric ultrasonography is a newly developed tool used to
evaluate gastric content and volume in assessing perioperative aspiration risk and guide
anaesthetic management. Gastric antrum is the most amenable and most consistently identified
region for sonographic examination during assessment even in empty state. Baseline gastric
secretions and clear fluids i.e: water, apple juice and tea have hypoechoeic or anechoic
appearance, whilst milk, thick fluids, or suspensions will have increased echogenicity.
Evaluation with sonographic assessment were found to be accurately reflective of gastric
content in various studies.
In this study, healthy volunteers were recruited. They will be required to fast at least 8
hours prior to baseline gastric antrum ultrasonography assessment. Following that, they will
require to drink 250ml glucose loaded drinks. Repeated Ultrasound assessment will be done
after 1 hour of glucose loaded drink ingestion in Group 1 and after 2 hours in Group 2.
Hypothesis of the study is there will be no significant different between ultrasound
assessment between this 2 groups.
This prospective randomized controlled trial study will be conducted in the Department of
Anaesthesiology and Intensive Care UKM for eight months period from November 2018 to June
2019 involving healthy adult volunteers comprising staff members of Department of
Anaesthesiology and Intensive Care, after obtaining approval from Research Committee of the
Department of Anaesthesiology & Intensive Care, Hospital Canselor Tuanku Muhriz, Universiti
Kebangsaan Malaysia Medical Centre (UKMMC) and the Medical Research & Ethics Committee,
UKMMC. Written informed consent will be obtained from volunteers who fulfill the inclusion
criteria.
All volunteers will be fasted, a minimum of 8 hours (duration of fasting will be recorded
before the study begin) and will undergo baseline ultrasonographic gastric assessment (t0).
All subjects in Group 1 and group 2 will drink 250 ml of lychee juice (glucose loaded clear
fluid containing solution with lychee flavor; 145 kcal in 250 ml) after completion of
baseline gastric assessment.
Group 1 subjects will then continue fasting for one hour until completion of second
sonographic antral assessment. Subjects in Group 2 will continue fasting for 2 hours until
second sonographic antral assessment scan is completed.
Subjects will be divided into 2 groups via computer randomization which will be allocated by
anaesthesia trainee that will not be taking part in the analytical and further write up
phases of the study. Ultrasonographic volume assessment will be conducted by a single
operator who is an anaesthesia Masters trainee, experienced in diagnostic abdominal
ultrasound with more than 20 sonographic gastric volume assessments. The images will be
recorded and validated by a consultant radiologist.
Ultrasonographic views of antral area will be obtained using a curvilinear array 2- to 5-MHz
transducer and a Mindray DC-70 (Shanghai, China) with image compounding technologies. Images
will be obtained with the stomach at rest, and between peristaltic contractions. Sonograms of
the antral area will be examined in 2 views, cross-section in the supine position, followed
by the right lateral decubitus position, at each of the two scanning sessions.
During ultrasonography, the antrum will be imaged in a parasagittal plane in the epigastric
area using the left lobe of the liver, the inferior vena cava, and the superior mesenteric
vein as internal landmarks. The two vessels are usually visualized slightly to the right of
the abdominal midline. Once these vessels were identified, the transducer will be rotated
slightly clockwise or counterclockwise to best obtain a true cross-sectional view of the
antrum. The anteroposterior and craniocaudal diameters will be measured in this view.
CSA of the antral area (a two-dimensional section) will be calculated according to the
formula previously used by Bolondi18 using two maximum perpendicular diameters.
This formula essentially represents the surface area of an ellipse, as follows: CSA (AP x CC
x pie/4), where AP is the anteroposterior diameter and CC is the craniocaudal diameter
measures in one decimal point.
Estimation of gastric volume will be obtain using this formula:
Predicted gastric volume based on right lateral CSA value : 27 + 14.6 * right lat CSA -
1.28*age (negative volume value indicates and empty state).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05445440 -
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
|
Phase 1 | |
Completed |
NCT03712540 -
An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants
|
Phase 1 | |
Completed |
NCT03649165 -
A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT05956002 -
A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy Participants
|
Phase 1 | |
Completed |
NCT05539976 -
A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
|
||
Withdrawn |
NCT04558216 -
Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants
|
Phase 1 | |
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Completed |
NCT06097390 -
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
|
Phase 1 | |
Completed |
NCT05546151 -
A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent
|
Phase 1 | |
Completed |
NCT05056246 -
Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants
|
Phase 1 | |
Completed |
NCT04390776 -
Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.
|
Phase 1 | |
Completed |
NCT05074459 -
A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines
|
Phase 1 | |
Enrolling by invitation |
NCT06089109 -
Creating VIP Corps to Reduce Maternal Deaths
|
N/A | |
Completed |
NCT05996250 -
Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects
|
N/A | |
Completed |
NCT03278080 -
Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1
|
N/A | |
Completed |
NCT05064800 -
PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT04471298 -
A Study of Qishenyiqi Dripping Pills in Healthy Participants
|
Phase 1 | |
Completed |
NCT04914936 -
A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196
|
Phase 1 | |
Completed |
NCT01681186 -
A Study of LY2940680 in Healthy Participants
|
Phase 1 | |
Completed |
NCT02882386 -
Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements
|
N/A |